Shares Of Biogen Jump 7% After Hours On Earnings, Increased Sales Of Multiple Sclerosis Drug
January 29, 2015 at 20:25 PM EST
Biogen increases in sales of its popular multiple sclerosis drug Tecfidera; net income accelerates.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.